PFIZER INC Proceeds from Equity Method Investment, Distribution, Return of Capital
PFIZER INC (PFE) reported Proceeds from Equity Method Investment, Distribution, Return of Capital of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-27.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital · last filed 2025-02-27
- PFIZER INC proceeds from equity method investment, distribution, return of capital for the quarter ending 2023-12-31 was $0.00.
- PFIZER INC proceeds from equity method investment, distribution, return of capital for the quarter ending 2022-12-31 was $0.00.
- PFIZER INC proceeds from equity method investment, distribution, return of capital for the quarter ending 2021-12-31 was $0.00.
- PFIZER INC proceeds from equity method investment, distribution, return of capital for fiscal 2024 was $0.00.
- PFIZER INC proceeds from equity method investment, distribution, return of capital for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- PFIZER INC proceeds from equity method investment, distribution, return of capital for fiscal 2022 was $3.96B.
- PFIZER INC proceeds from equity method investment, distribution, return of capital for fiscal 2021 was $0.00.
| Period end | Proceeds from Equity Method Investment, Distribution, Return of Capital 3 month | Proceeds from Equity Method Investment, Distribution, Return of Capital 9 month | Proceeds from Equity Method Investment, Distribution, Return of Capital 12 month |
|---|---|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-27 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 10-K · filed 2025-02-27 | |
| 2023-10-01 | $0.00 10-Q · filed 2023-11-08 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $3.96B 10-K · filed 2025-02-27 | |
| 2022-10-02 | $3.96B 10-Q · filed 2023-11-08 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $0.00 10-K · filed 2024-02-22 | |
| 2021-10-03 | $0.00 10-Q · filed 2022-11-09 | ||
| 2020-12-31 | $0.00 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |